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Abstract
Background: Various types of noninvasive respiratory modalities that lead to successful extubation in preterm
infants have been explored. We aimed to compare noninvasive neurally adjusted ventilatory assist (NIV-NAVA) and
nasal continuous positive airway pressure (NCPAP) for the postextubation stabilization of preterm infants.
Methods: This retrospective study was divided into two distinct periods, between July 2012 and June 2013 and
between July 2013 and June 2014, because NIV-NAVA was applied beginning in July 2013. Preterm infants of less
than 30 weeks GA who had been intubated with mechanical ventilation for longer than 24 h and were weaned to
NCPAP or NIV-NAVA after extubation were enrolled. Ventilatory variables and extubation failure were compared
after weaning to NCPAP or NIV-NAVA. Extubation failure was defined when infants were reintubated within 72 h of
extubation.
Results: There were 14 infants who were weaned to NCPAP during Period I, and 2 infants and 16 infants were
weaned to NCPAP and NIV-NAVA, respectively, during Period II. At the time of extubation, there were no
differences in the respiratory severity score (NIV-NAVA 1.65 vs. NCPAP 1.95), oxygen saturation index (1.70 vs. 2.09)
and steroid use before extubation. Several ventilation parameters at extubation, such as the mean airway pressure,
positive end-expiratory pressure, peak inspiratory pressure, and FiO2, were similar between the two groups. SpO2
and pCO2 preceding extubation were comparable. Extubation failure within 72 h after extubation was observed in
6.3% of the NIV-NAVA group and 37.5% of the NCPAP group (P = 0.041).
Conclusions: The data in the present showed promising implications for using NIV-NAVA over NCPAP to facilitate
extubation.
Keywords: Airway extubation, Continuous positive airway pressure, Neurally adjusted ventilator assist, Noninvasive
ventilation, Ventilator weaning
Background
Invasive mechanical ventilation (MV) is frequently required
in preterm infants after birth to maintain adequate alveolar
ventilation and effective gas exchange. However, tracheal
intubation and MV in preterm neonates can induce ventila-
tor-induced lung injury (VILI) and airway inflammation [1,
2]. Prolonged MV in preterm infants also increases the risk
of ventilator-associated pneumonia, increasing the length of
hospital stays, mortality, and neurologic impairment [3].
Therefore, noninvasive respiratory modalities have been
used in preterm infants to facilitate the transition to spon-
taneous breathing following extubation [4–7].
Nasal continuous positive airway pressure (NCPAP) main-
tains functional residual capacity while improving lung com-
pliance and oxygenation. NCPAP has been widely used in
the neonatal intensive care unit (NICU) and has proven to
be effective in preventing failure of extubation in preterm in-
fants [8]. However, studies have reported that extubation
failure rates ranged from 25 to 35% among preterm infants
who were given NCPAP after extubation [9, 10]. Nasal inter-
mittent positive pressure ventilation (NIPPV) augments
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NCPAP by superimposing ventilator inflation on NCPAP
[11]. Although synchronized (SNIPPV) or nonsynchronized
techniques can be used to supplement the infants’ own
breathing efforts, it is likely that more effective support can
be achieved with SNIPPV [12, 13]. To date, pneumatic cap-
sules or flow sensors have been used to detect inspiration
for synchronization, but some limitations in clinical practice
have been reported [14–16].
Neurally adjusted ventilatory assist (NAVA) improves
synchrony in patients with respiratory support by detecting
the electrical activity of the diaphragm and may offer
potential benefits in neonatal ventilation [17–20]. Noninva-
sive ventilation using NAVA as a triggering modality (NIV-
NAVA) could be effective, as demonstrated in adult
populations [21, 22]. To date, few studies of NIV-NAVA in
preterm infants have been conducted. Patient-ventilator
synchrony and effective diaphragmatic unloading were
reported in preterm infants during NAVA-derived
noninvasive nasal ventilation [23]. Herein, we aimed to
compare NIV-NAVA and NCPAP for the postextubation
stabilization of very low birth weight infants.
Methods
This study used a retrospective approach and was approved
by the Institutional Review Board of Seoul National Univer-
sity Hospital. The study included preterm infants of less
than 30weeks gestational age (GA) who were admitted to
the NICU of the Seoul National University Children’s Hos-
pital (SNUCH) between July 2012 and June 2014 and sur-
vived more than 72 h. Infants who were on MV for longer
than 24 h and were weaned to NCPAP (Infant Flow system,
Viasys, Healthcare, Pennsylvania, United States) or NIV-
NAVA (SERVO-I, Maquet Critical Care AB, Solna,
Sweden) after extubation were eligible for the study. The
size of the Edi catheter used during the study period was 6
Fr/49 cm, which could be used for extremely preterm in-
fants [20]. There were no postmenstrual age (PMA) criteria
for the use of NIV-NAVA during the study period if self-
respiration was well established in the baby. Infants who
had major congenital anomalies or who were intubated for
longer than 6 weeks were excluded from the study. The
study period was divided into two distinct periods, namely
between July 2012 and June 2013 (Period I) and between
July 2013 and June 2014 (Period II), because NIV-NAVA
was applied at SNUCH beginning in July 2013.
The respiratory severity score (RSS =mean airway
pressure (cmH2O) x FiO2) and oxygen saturation index
(OSI =MAP x FiO2 × 100 ÷ SpO2) were used to com-
pare the pre-extubation respiratory conditions between
the two groups [24, 25]. The RSS has been used to pre-
dict extubation readiness or the length of mechanical
ventilation in preterm infants, and the OSI has been sug-
gested to be a useful measurement to reliably assess the
severity of respiratory conditions in preterm infants
when the oxygen index is not available [26, 27]. During
the study period, extubation was performed if the patient
remained stable with a SpO2 > 90% for at least 6 h while
on the following settings: mean airway pressure (MAP) ≤
9 cmH2O, positive end expiratory pressure (PEEP) ≤ 7
cmH2O and fraction of inspired oxygen (FiO2) ≤ 40%. In
infants who were mechanically ventilated for longer than
15 days, dexamethasone was administered to reduce air-
way edema. All infants included in the study population
were treated with caffeine. A capillary blood gas analysis
was performed within 1 h after extubation. Postextuba-
tion PEEP was initially set to 5~6 cmH2O both in the
NCPAP and NIV-NAVA groups, and was then adjusted
within a range of 4~8 cmH2O according to the clini-
cian’s discrimination. The NAVA level was initially set
to 1.0~1.5 cmH2O/μV and adjusted to obtain pCO2 < 70
mmHg. In both ventilation strategies, binasal prongs and
masks were used alternatively every 24 h to minimize
nasal injury.
The primary outcome of the study was extubation fail-
ure within 72 h after extubation, which was defined ac-
cording to a set of conditions for reintubation and the
reapplication of MV [28]. Infants with severe apnea re-
quiring positive pressure ventilation (PPV), ≥ 4 apneic
episodes per hour needing moderate stimulation, FiO2 >
60%, or uncompensated respiratory acidosis (pH < 7.25)
were reintubated during the study period. Backup venti-
lation at a rate of 30/min and pressure of 10–15 cmH2O
above PEEP was applied if Edi was absent or apnea oc-
curred for more than 5–10 s and the upper pressure
limit was set to 20–25 cmH2O [23].
All statistical analyses were performed with STATA
11.0 (Stata Corp, College Station, TX, USA) using the
independent t-test for continuous variables and the χ2-
test and Fisher’s exact test for categorical variables. For
all statistical analyses, P < 0.05 was considered statisti-
cally significant.
Results
A total of 64 infants in Period I and 51 infants in Period
II who were born at less than 30 weeks of gestation and
survived greater than 72 h were admitted (Fig. 1). Two
infants from Period I were excluded: one infant had
Beckwith-Wiedemann syndrome, and the other infant
had Galen malformation of the brain. Sixteen infants in
Period I and 13 infants in Period II who were never intu-
bated or intubated less than 24 h were also excluded.
After excluding infants who had been intubated for
greater than 6 weeks, those who were never extubated or
died before discharge, and those who were weaned to
other modalities, such as heated and humidified high
flow nasal cannula (HHHFNC), there were 14 infants
who were weaned to NCPAP during Period I and 16 in-
fants who were weaned to NIV-NAVA during Period II.
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The 2 infants who were weaned to NCPAP during
Period II were categorized as the NCPAP group with the
infants from Period I.
The GA and birth weight of the NIV-NAVA group
and NCPAP group were not significantly different (27+ 1
vs. 26+ 5 weeks and 875 vs. 845 g, respectively) (Table 1).
The incidence of RDS, maternal histologic chorioamnio-
nitis and antenatal steroid use were also not significantly
different between the two groups. At the time of extuba-
tion, PMA and weight exhibited no significant differ-
ences between the NIV-NAVA group and NCPAP
group (30 vs. 29+ 4 weeks and 1045 vs. 1205 g, respect-
ively) (Table 2). No differences in RSS (NIV-NAVA 1.65
vs. NCPAP 1.95), OSI (1.70 vs. 2.09) or steroid use were
noted before extubation. Several ventilation parameters
at extubation, such as MAP, PEEP, PIP peak inspiratory
pressure (PIP), and FiO2, were similar between the two
groups. SpO2 and pCO2 preceding extubation were also
comparable.
Extubation failure within 72 h after extubation was ascer-
tained in 1 (6.3%) infant in the NIV-NAVA group and 6
(37.5%) infants in the NCPAP group (P = 0.041) (Table 3).
One infant in the NIV-NAVA group was reintubated 11 h
after extubation because of severe apnea requiring PPV. In
the NCPAP group, 3 infants were reintubated before 24 h
after extubation, 2 infants were reintubated 24–48 h after
extubation and one infant was reintubated 70 h after extu-
bation (Fig. 2). Three infants were reintubated because of
severe apnea requiring PPV, two infants due to uncompen-
sated respiratory acidosis (pH < 7.25) with pCO2 > 70
mmHg and one infant due to ≥4 apneic episodes per hour
needing moderate stimulation. The use of other respiratory
support parameters after extubation, such as PEEP and
FiO2, were comparable between the NCPAP and NIV-
NAVA groups with similar pCO2 and SpO2. Among those
who were reintubated in the study, GA at birth was 26.4
weeks in the NIV-NAVA group and 25.9 (25.3–28.1) weeks
in the NCPAP group. In the univariate logistic regression
analysis, GA at extubation and the duration of invasive
Fig. 1 Selection of the study population during the study period






GA (weeks) 27+ 1 (26+ 5, 27+ 6) 26+ 5 (25+ 4, 27+ 6) 0.317
Birth weight (grams) 875 (677.5, 1145) 845 (700, 1030) 0.777
Male 11 (68.8) 7 (43.8) 0.143
C/S 8 (50.0) 7 (43.8) 0.500
Multiple births 12 (75.0) 10 (62.5) 0.352
PIH 4 (25.0) 1 (6.25) 0.166
hCAM 5 (31.3) 10 (62.5) 0.078
PPROM 7 (43.8) 6 (37.5) 0.500
Antenatal steroid 7 (43.8) 12 (75.0) 0.074
1-min AS 3 (2, 5) 3.5 (2, 4.5) 0.802
5-min AS 5.5 (4, 7) 7 (6, 7) 0.122
RDS 14 (87.5) 16 (100) 0.242
PDA 12 (75.0) 7 (73.3) 0.618
Values are presented as the median (interquartile range) or n (%)
NIV-NAVA Noninvasive neurally adjusted ventilatory assist, NCPAP Nasal
continuous positive airway pressure, GA Gestational age, C/S Cesarean section,
PIH Pregnancy induced hypertension, hCAM Histologic chorioamnionitis,
PPROM Preterm premature rupture of membrane, AS Apgar score, RDS
Respiratory distress syndrome, PDA Patent ductus arteriosus
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ventilation before extubation were not associated with rein-
tubation (data not shown).
No differences were noted between the two groups re-
garding the other clinical outcomes, including the devel-
opment of moderate to severe bronchopulmonary
dysplasia (BPD) (Table 4).
Discussion
Extubation failure is often observed in preterm infants
because the chest wall and upper airway collapses easily
and diaphragmatic strength is poor [29, 30]. The present
study revealed that NIV-NAVA facilitated extubation bet-
ter than NCPAP. Following a period of endotracheal in-
tubation and IPPV, NCPAP is effective for preventing
extubation failure in preterm infants [8]. This technique
appears to improve lung function and reduce apnea and
may therefore play a role in facilitating extubation in this
population. However, certain populations among preterm
infants who were subject to NCPAP experienced extuba-
tion failure [6, 31–33].
NIPPV augments NCPAP by delivering ventilator
breaths via nasal prongs or a mask. Although it did not
improve ventilation in infants who were able to maintain
their own ventilation on NCPAP, in infants with a
higher baseline PaCO2, ventilation was more effectively
increased by NIPPV than NCPAP [34]. Severe apnea and
increased PaCO2 were the most common causes of fail-
ure in infants receiving NCPAP, and NIPPV achieved a
comparative reduction in extubation failure in preterm
infants. A recent meta-analysis demonstrated that the in-
cidence of extubation failure and the need for reintuba-
tion within 48 h to 1 week was reduced by NIPPV in
preterm infants [12]. However, synchronization and the
device used to deliver PPV may be important parameters
in NIPPV [13].
NAVA has been applied in clinical practice during the last
decade, but studies have rarely involved neonates, especially
the preterm infant population. However, a recent study
demonstrated the effectiveness and feasibility of NAVA in
this population [19]. Noninvasive support via NAVA im-
proved patient-ventilator synchrony by reducing trigger
delay and the number of asynchrony events [35]. Previously,
we reported that NAVA improved patient-ventilator syn-
chrony and diaphragmatic unloading in preterm infants dur-
ing noninvasive nasal ventilation compared with pressure
support mode [23]. A recent physiologic study performed
by Gibu et al. compared NIV-NAVA and NIPPV and dem-
onstrated that peak inspiratory pressure and FiO2 were low-
ered in NIV-NAVA than in NIPPV [36]. Furthermore, both
infant movement and caretaker’s work were lowered in






PMA at extubation (weeks) 30 (28+ 6, 31+ 4) 29+ 4 (27+ 3, 30+ 4) 0.282
Weight at extubation (grams) 1045 (800, 1325) 1025 (905, 1190) 0.651
Pre-extubation
Ventilator duration (days) 21.5 (11.5, 27) 9.5 (4.5, 34.5) 0.365
Systemic steroid use 7 (43.8) 5 (31.3) 0.358
RSS 1.65 (1.49, 2.28) 1.95 (1.68, 2.32) 0.317
OSI 1.70 (1.53, 2.39) 2.09 (1.76, 2.51) 0.274
MAP (cmH2O) 7 (7, 7.5) 8 (7, 8) 0.212
PEEP (cmH2O) 5 (5, 5) 5 (5, 6) 0.531
PIP (cmH2O) 13 (12, 14) 15 (12, 16) 0.180
FiO2 (%) 0.24 (0.21, 0.31) 0.25 (0.21, 0.30) 0.700
pCO2 (mmHg) 53.2 (45.0, 58.4) 49.1 (43.7, 65.3) 0.970
SpO2 (mmHg) 95.5 (94, 98.5) 96 (93.5, 97) 0.760
Values are presented as the median (interquartile range) or n (%)
NIV-NAVA Noninvasive neurally adjusted ventilatory assist, NCPAP Nasal continuous positive airway pressure, PMA Postmenstrual age, RSS Respiratory severity
score, OSI Oxygen saturation index, MAP Mean airway pressure, PEEP Positive end-expiratory pressure, PIP Peak inspiratory pressure






PEEP (cmH2O) 6 (5.5, 6) 6 (5, 7) 1.000
FiO2 (%) 0.30 (0.27, 0.35) 0.25 (0.21, 0.33) 0.109
pCO2 (mmHg) 48.5 (44.3, 53.6) 49.7 (40.7, 62.1) 0.695
SpO2 (mmHg) 96 (93, 97) 96.5 (94, 98) 0.597
Extubation failure ≤72 h 1 (6.3) 6 (37.5) 0.041
Values are presented as the median (interquartile range) or n (%). Post-
extubation status was checked 1 h after extubation
NIV-NAVA Noninvasive neurally adjusted ventilatory assist, NCPAP Nasal
continuous positive airway pressure, PMA Postmenstrual age, RSS Respiratory
severity score, OSI Oxygen saturation index, MAP Mean airway pressure, PEEP
Positive end-expiratory pressure, PIP Peak inspiratory pressure
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NIV-NAVA, suggesting that NIV-NAVA was more effective
than NIPPV at increasing infant comfort. Because it has ex-
cellent synchronization, NIN-NAVA could serve as a substi-
tute for NCPAP to facilitate extubation in preterm infants.
Most cases of reintubation in this study were the result of
severe apnea or uncompensated hypercapnia. When com-
pared to NCPAP, apnea and hypercapnia were more pre-
ventable in NIPPV by generating higher airway pressure to
prevent obstructive apnea and triggering sigh in preterm in-
fants [37, 38]. Although NIV-NAVA seemed to improve
ventilator synchrony and diaphragmatic unloading during
noninvasive ventilation compared to other NIPPV, there
was no evidence that NIV-NAVA is superior to other
NIPPV modalities after extubation [23, 39].
Even though there could be concerns regarding the
size of the baby when using NIV-NAVA, many studies
showed NIV-NAVA was feasible in extremely preterm
infants [23, 39]. In the present study, NIV-NAVA was
also found to be feasible in babies as small as 660 g at
extubation or 700 g at birth who were successfully
weaned to NIV-NAVA at PMA 28 weeks. A baby who
was 500 g at birth was also successfully weaned to NIV-
NAVA at 770 g. Moreover, Edi catheters can efficiently
serve as a feeding tube in these babies and thus an add-
itional feeding tube did not need to be inserted for en-
teral feeding. NEC was comparable in both groups and
there were no intestinal perforations or air leaks after
the infants were weaned to NIV-NAVA or NCPAP. Al-
though the rates of neonatal complications are lower in
noninvasive versus invasive MV, safety must be consid-
ered. Previously, it was suggested that neonates who
were mechanically ventilated with either a face mask or
nasal prongs had an increased risk of gastrointestinal
perforations. However, recent data has shown that
NIPPV does not appear to be associated with increased
gastrointestinal side effects, and the risk of air leaks was
lower in NIPPV than in NCPAP [40]. No differences in
the development of air leaks and NEC were observed be-
tween the two groups in the present study.
There are some limitations to the present study. This
study was a retrospective study with a small sample size,
thus making it difficult to draw robust conclusions. There
also was a period of overlap when both NIV-NAVA and
NCPAP were used as weaning modalities. The study popu-
lation was highly selected because we analyzed only 50% of
the preterm infants born at < 30 weeks of gestation who
were intubated for more than 24 h and were extubated
thereafter during the study period. Furthermore, the dur-
ation of ventilation seemed to be shorter in the NCPAP
Fig. 2 Kaplan-Meier estimates for extubation success by post-extubation modality
Table 4 Clinical outcomes of the study population
NIV-NAVA (n=16) NCPAP (n = 16) P value
Moderate to severe BPD 10 (62.5) 9 (60.0) 0.589
NEC≥ stage 2 2 (12.5) 5 (33.3) 0.170
Retinopathy of prematurity 4 (25.0) 6 (40.0) 0.306
IVH≥ grade 2 2 (12.5) 1 (6.7) 0.525
Periventricular leukomalacia 1 (6.3) 0 (0) 0.516
Values are presented as the median (interquartile range) or n (%)
NIV-NAVA Noninvasive neurally adjusted ventilatory assist, NCPAP Nasal
continuous positive airway pressure, BPD Bronchopulmonary dysplasia, NEC
Necrotizing enterocolitis, ROP Retinopathy of prematurity, IVH
Intraventricular hemorrhage
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group, although this result was not statistically significant.
While the sample size may have been too small to fully elu-
cidate this difference, a logistic regression analysis for rein-
tubation was performed ad hoc and showed that the
duration of ventilation before extubation was not associated
with reintubation (data not shown). The criteria for extuba-
tion were well-defined in our unit, and the pre-extubation
conditions in both groups including the PMA at extuba-
tion, RSS, OSI and the ventilation settings were comparable
in the present study. Despite these limitations, this is the
first study to compare the clinical responses between NIV-
NAVA and NCPAP when used to facilitate extubation in
preterm infants.
Conclusions
The data in the present study were not robust enough to
be conclusive due to small sample size, but showed prom-
ising implications for using NIV-NAVA over NCPAP to
facilitate extubation. NIV-NAVA could be an effective
modality for synchronized noninvasive ventilation follow-
ing successful extubation from MV in preterm infants.
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